The Resistance Exercise Training for Worry Trial

October 3, 2019 updated by: University of Limerick

Effects of Resistance Exercise Among Young Adults With and Without Analogue Generalized Anxiety Disorder: A Protocol for a Randomized Controlled Trial

This protocol details the full methods of two parallel, randomized controlled trials of an eight-week resistance exercise training intervention compared to a wait-list control condition among young adults with and without analogue-Generalized Anxiety Disorder.

Study Overview

Detailed Description

Recent meta-analyses support the chronic anxiolytic effects of resistance exercise training among women with diagnosed Generalized Anxiety Disorder. However, the effects of resistance exercise training among those with subclinical, or analogue-Generalized Anxiety Disorder is unknown. This protocol details the full methods of two parallel, randomized controlled trials of an eight-week resistance exercise training intervention compared to a wait-list control condition among young adults with and without analogue-Generalized Anxiety Disorder. Analogue-Generalized Anxiety Disorder status was determined using validated cut-scores for both the Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder sub-scale score of 6 or greater, and the Penn State Worry Questionnaire score of 45 or greater. The ecologically-valid resistance exercise training was designed according to World Health Organization and American College of Sports Medicine guidelines.

Study Type

Interventional

Enrollment (Actual)

95

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Limerick, Ireland
        • The Department of Physical Education and Sport Sciences Building

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Inclusion criteria were age 18-40y; no medical contraindication to safe participation in resistance exercise training; and no current pregnancy or lactation.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Analogue-Generalized Anxiety Disorder Resistance Training
Resistance exercise training among young adults with analogue-Generalized Anxiety Disorder
The ecologically-valid resistance exercise training was designed according to World Health Organization and American College of Sports Medicine guidelines. The eight-week, twice-weekly intervention was designed to be performed at a moderate intensity. The resistance of each exercise was such that when participants could successfully complete 2 sets of 12 repetitions at a certain load, the resistance was increased incrementally up to 5% for the following session. Exercise sessions were scheduled with at least one day of rest between sessions. The eight exercises included the barbell squat, barbell bench press, hexagon bar deadlift, dumbbell shoulder lateral raise, barbell bent over rows, dumbbell lunges, dumbbell curls, and abdominal crunches.
Other Names:
  • strength training
  • weight-lifting
Other: Analogue-Generalized Anxiety Disorder Wait-List
8-week wait-list control condition among young adults with analogue-Generalized Anxiety Disorder
Participants randomized to the delayed-start wait-list condition completed questionnaires once-weekly. The investigator sent a weekly email to the participant providing links to the questionnaires. Participants that completed the eight-week wait-list condition were offered the eight weeks of RET either immediately upon completion, or later at a time of their convenience while the trial was ongoing. Each participant randomized to the eight-week wait-list also completed two 30-minute bouts of seated quiet rest in an empty room at weeks one and eight.
Experimental: Non-Analogue-Generalized Anxiety Disorder Resistance Training
Resistance exercise training among young adults without analogue-Generalized Anxiety Disorder
The ecologically-valid resistance exercise training was designed according to World Health Organization and American College of Sports Medicine guidelines. The eight-week, twice-weekly intervention was designed to be performed at a moderate intensity. The resistance of each exercise was such that when participants could successfully complete 2 sets of 12 repetitions at a certain load, the resistance was increased incrementally up to 5% for the following session. Exercise sessions were scheduled with at least one day of rest between sessions. The eight exercises included the barbell squat, barbell bench press, hexagon bar deadlift, dumbbell shoulder lateral raise, barbell bent over rows, dumbbell lunges, dumbbell curls, and abdominal crunches.
Other Names:
  • strength training
  • weight-lifting
Other: Non-Analogue-Generalized Anxiety Disorder Wait-List
8-week wait-list control condition among young adults with analogue-Generalized Anxiety Disorder
Participants randomized to the delayed-start wait-list condition completed questionnaires once-weekly. The investigator sent a weekly email to the participant providing links to the questionnaires. Participants that completed the eight-week wait-list condition were offered the eight weeks of RET either immediately upon completion, or later at a time of their convenience while the trial was ongoing. Each participant randomized to the eight-week wait-list also completed two 30-minute bouts of seated quiet rest in an empty room at weeks one and eight.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analogue-Generalized Anxiety Disorder Status
Time Frame: Baseline
The Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman & Mattia, 2001, Arch of Gen Psychiatr)
Baseline
Analogue-Generalized Anxiety Disorder Status
Time Frame: week1
The Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman & Mattia, 2001, Arch of Gen Psychiatr)
week1
Analogue-Generalized Anxiety Disorder Status
Time Frame: week 4
The Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman & Mattia, 2001, Arch of Gen Psychiatr)
week 4
Analogue-Generalized Anxiety Disorder Status
Time Frame: week 8
The Psychiatric Diagnostic Screening Questionnaire Generalized Anxiety Disorder subscale score of 6 or greater (Zimmerman & Mattia, 2001, Arch of Gen Psychiatr)
week 8
Analogue-Generalized Anxiety Disorder Status
Time Frame: Baseline
The Penn State Worry Questionnaire score of 45 or greater (Meyer et al., 1990, Behav Res and Ther)
Baseline
Analogue-Generalized Anxiety Disorder Status
Time Frame: week1
The Penn State Worry Questionnaire score of 45 or greater (Meyer et al., 1990, Behav Res and Ther)
week1
Analogue-Generalized Anxiety Disorder Status
Time Frame: week 4
The Penn State Worry Questionnaire score of 45 or greater (Meyer et al., 1990, Behav Res and Ther)
week 4
Analogue-Generalized Anxiety Disorder Status
Time Frame: week 8
The Penn State Worry Questionnaire score of 45 or greater (Meyer et al., 1990, Behav Res and Ther)
week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety Symptoms
Time Frame: Baseline
State and trait anxiety were measured using the State (STAI-Y1) and Trait (STAI-Y2) subscales of the State-Trait Anxiety Inventory (Spielberger, 2010, Corsini Encycl of Psychol)
Baseline
Anxiety Symptoms
Time Frame: week 1
State and trait anxiety were measured using the State (STAI-Y1) and Trait (STAI-Y2) subscales of the State-Trait Anxiety Inventory (Spielberger, 2010, Corsini Encycl of Psychol)
week 1
Anxiety Symptoms
Time Frame: week 2
State and trait anxiety were measured using the State (STAI-Y1) and Trait (STAI-Y2) subscales of the State-Trait Anxiety Inventory (Spielberger, 2010, Corsini Encycl of Psychol)
week 2
Anxiety Symptoms
Time Frame: week 3
State and trait anxiety were measured using the State (STAI-Y1) and Trait (STAI-Y2) subscales of the State-Trait Anxiety Inventory (Spielberger, 2010, Corsini Encycl of Psychol)
week 3
Anxiety Symptoms
Time Frame: week 4
State and trait anxiety were measured using the State (STAI-Y1) and Trait (STAI-Y2) subscales of the State-Trait Anxiety Inventory (Spielberger, 2010, Corsini Encycl of Psychol)
week 4
Anxiety Symptoms
Time Frame: week 5
State and trait anxiety were measured using the State (STAI-Y1) and Trait (STAI-Y2) subscales of the State-Trait Anxiety Inventory (Spielberger, 2010, Corsini Encycl of Psychol)
week 5
Anxiety Symptoms
Time Frame: Week 6
State and trait anxiety were measured using the State (STAI-Y1) and Trait (STAI-Y2) subscales of the State-Trait Anxiety Inventory (Spielberger, 2010, Corsini Encycl of Psychol)
Week 6
Anxiety Symptoms
Time Frame: Week 7
State and trait anxiety were measured using the State (STAI-Y1) and Trait (STAI-Y2) subscales of the State-Trait Anxiety Inventory (Spielberger, 2010, Corsini Encycl of Psychol)
Week 7
Anxiety Symptoms
Time Frame: Week 8
State and trait anxiety were measured using the State (STAI-Y1) and Trait (STAI-Y2) subscales of the State-Trait Anxiety Inventory (Spielberger, 2010, Corsini Encycl of Psychol)
Week 8
Depressive Symptoms
Time Frame: Baseline
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003, Bio Psychiatr)
Baseline
Depressive Symptoms
Time Frame: Week 1
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003, Bio Psychiatr)
Week 1
Depressive Symptoms
Time Frame: Week 2
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003, Bio Psychiatr)
Week 2
Depressive Symptoms
Time Frame: Week 3
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003, Bio Psychiatr)
Week 3
Depressive Symptoms
Time Frame: Week 4
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003, Bio Psychiatr)
Week 4
Depressive Symptoms
Time Frame: Week 5
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003, Bio Psychiatr)
Week 5
Depressive Symptoms
Time Frame: Week 6
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003, Bio Psychiatr)
Week 6
Depressive Symptoms
Time Frame: Week 7
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003, Bio Psychiatr)
Week 7
Depressive Symptoms
Time Frame: Week 8
16-item Quick Inventory of Depressive Symptomatology (Rush et al., 2003, Bio Psychiatr)
Week 8
Mood
Time Frame: Baseline
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
Baseline
Mood
Time Frame: Week 1
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
Week 1
Mood
Time Frame: Week 2
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
Week 2
Mood
Time Frame: Week 3
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
Week 3
Mood
Time Frame: Week 4
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
Week 4
Mood
Time Frame: Week 5
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
Week 5
Mood
Time Frame: Week 6
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
Week 6
Mood
Time Frame: Week 7
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
Week 7
Mood
Time Frame: Week 8
Subscales of the Profile of Mood States - Brief Form (McNair et al., 1992)
Week 8
Irritability
Time Frame: Baseline
21-item Irritability Questionnaire (Craig et al., 2008, Psychiatr Res)
Baseline
Irritability
Time Frame: Week 1
21-item Irritability Questionnaire (Craig et al., 2008, Psychiatr Res)
Week 1
Irritability
Time Frame: Week 2
21-item Irritability Questionnaire (Craig et al., 2008, Psychiatr Res)
Week 2
Irritability
Time Frame: Week 3
21-item Irritability Questionnaire (Craig et al., 2008, Psychiatr Res)
Week 3
Irritability
Time Frame: Week 4
21-item Irritability Questionnaire (Craig et al., 2008, Psychiatr Res)
Week 4
Irritability
Time Frame: Week 5
21-item Irritability Questionnaire (Craig et al., 2008, Psychiatr Res)
Week 5
Irritability
Time Frame: Week 6
21-item Irritability Questionnaire (Craig et al., 2008, Psychiatr Res)
Week 6
Irritability
Time Frame: Week 7
21-item Irritability Questionnaire (Craig et al., 2008, Psychiatr Res)
Week 7
Irritability
Time Frame: Week 8
21-item Irritability Questionnaire (Craig et al., 2008, Psychiatr Res)
Week 8
Sleep Quality
Time Frame: Baseline
Pittsburgh Sleep Quality Index (Buysse et al., 1989, Psychiatr Res)
Baseline
Sleep Quality
Time Frame: Week 1
Pittsburgh Sleep Quality Index (Buysse et al., 1989, Psychiatr Res)
Week 1
Sleep Quality
Time Frame: Week 2
Pittsburgh Sleep Quality Index (Buysse et al., 1989, Psychiatr Res)
Week 2
Sleep Quality
Time Frame: Week 3
Pittsburgh Sleep Quality Index (Buysse et al., 1989, Psychiatr Res)
Week 3
Sleep Quality
Time Frame: Week 4
Pittsburgh Sleep Quality Index (Buysse et al., 1989, Psychiatr Res)
Week 4
Sleep Quality
Time Frame: Week 5
Pittsburgh Sleep Quality Index (Buysse et al., 1989, Psychiatr Res)
Week 5
Sleep Quality
Time Frame: Week 6
Pittsburgh Sleep Quality Index (Buysse et al., 1989, Psychiatr Res)
Week 6
Sleep Quality
Time Frame: Week 7
Pittsburgh Sleep Quality Index (Buysse et al., 1989, Psychiatr Res)
Week 7
Sleep Quality
Time Frame: Week 8
Pittsburgh Sleep Quality Index (Buysse et al., 1989, Psychiatr Res)
Week 8
Non-Intervention Physical Activity
Time Frame: Baseline
7-day Physical Activity Recall (Blair et al., 1985, Am J of Epidemiol)
Baseline
Non-Intervention Physical Activity
Time Frame: Week 1
7-day Physical Activity Recall (Blair et al., 1985, Am J of Epidemiol)
Week 1
Non-Intervention Physical Activity
Time Frame: Week 2
7-day Physical Activity Recall (Blair et al., 1985, Am J of Epidemiol)
Week 2
Non-Intervention Physical Activity
Time Frame: Week 3
7-day Physical Activity Recall (Blair et al., 1985, Am J of Epidemiol)
Week 3
Non-Intervention Physical Activity
Time Frame: Week 4
7-day Physical Activity Recall (Blair et al., 1985, Am J of Epidemiol)
Week 4
Non-Intervention Physical Activity
Time Frame: Week 5
7-day Physical Activity Recall (Blair et al., 1985, Am J of Epidemiol)
Week 5
Non-Intervention Physical Activity
Time Frame: Week 6
7-day Physical Activity Recall (Blair et al., 1985, Am J of Epidemiol)
Week 6
Non-Intervention Physical Activity
Time Frame: Week 7
7-day Physical Activity Recall (Blair et al., 1985, Am J of Epidemiol)
Week 7
Non-Intervention Physical Activity
Time Frame: Week 8
7-day Physical Activity Recall (Blair et al., 1985, Am J of Epidemiol)
Week 8
A novel questionnaire assessing expectancy of exercise to improve or not to improve physical and mental health outcomes. (Lindheimer et al., 2019, Eur J of Sport Sci)
Time Frame: Baseline
Participants are asked to what degree they believe a single bout of exercise will improve or worsen various domains of physical and mental health
Baseline
A novel questionnaire assessing expectancy of exercise to improve or not to improve physical and mental health outcomes. (Lindheimer et al., 2019, Eur J of Sport Sci)
Time Frame: Week 1
Participants are asked to what degree they believe a single bout of exercise will improve or worsen various domains of physical and mental health
Week 1
A novel questionnaire assessing expectancy of exercise to improve or not to improve physical and mental health outcomes. (Lindheimer et al., 2019, Eur J of Sport Sci)
Time Frame: Week 2
Participants are asked to what degree they believe a single bout of exercise will improve or worsen various domains of physical and mental health
Week 2
A novel questionnaire assessing expectancy of exercise to improve or not to improve physical and mental health outcomes. (Lindheimer et al., 2019, Eur J of Sport Sci)
Time Frame: Week 3
Participants are asked to what degree they believe a single bout of exercise will improve or worsen various domains of physical and mental health
Week 3
A novel questionnaire assessing expectancy of exercise to improve or not to improve physical and mental health outcomes. (Lindheimer et al., 2019, Eur J of Sport Sci)
Time Frame: Week 4
Participants are asked to what degree they believe a single bout of exercise will improve or worsen various domains of physical and mental health
Week 4
A novel questionnaire assessing expectancy of exercise to improve or not to improve physical and mental health outcomes. (Lindheimer et al., 2019, Eur J of Sport Sci)
Time Frame: Week 5
Participants are asked to what degree they believe a single bout of exercise will improve or worsen various domains of physical and mental health
Week 5
A novel questionnaire assessing expectancy of exercise to improve or not to improve physical and mental health outcomes. (Lindheimer et al., 2019, Eur J of Sport Sci)
Time Frame: Week 6
Participants are asked to what degree they believe a single bout of exercise will improve or worsen various domains of physical and mental health
Week 6
A novel questionnaire assessing expectancy of exercise to improve or not to improve physical and mental health outcomes. (Lindheimer et al., 2019, Eur J of Sport Sci)
Time Frame: Week 7
Participants are asked to what degree they believe a single bout of exercise will improve or worsen various domains of physical and mental health
Week 7
A novel questionnaire assessing expectancy of exercise to improve or not to improve physical and mental health outcomes. (Lindheimer et al., 2019, Eur J of Sport Sci)
Time Frame: Week 8
Participants are asked to what degree they believe a single bout of exercise will improve or worsen various domains of physical and mental health
Week 8
Attentional Biases
Time Frame: Baseline
Attentional bias to positive, negative, and neutral facial images (Gotlin et al., 2004, J of Abnorm Psychol)
Baseline
Attentional Biases
Time Frame: Week 1
Attentional bias to positive, negative, and neutral facial images (Gotlin et al., 2004, J of Abnorm Psychol)
Week 1
Attentional Biases
Time Frame: Week 8
Attentional bias to positive, negative, and neutral facial images (Gotlin et al., 2004, J of Abnorm Psychol)
Week 8
Cognitive Function
Time Frame: Baseline
Stroop colour and word test, (Williams et al., 1996, Psychol Bull) and Trail Making Test (Tombaugh, 2004, Arch of Clin Neuropsychol)
Baseline
Cognitive Function
Time Frame: Week1
Stroop colour and word test, (Williams et al., 1996, Psychol Bull) and Trail Making Test (Tombaugh, 2004, Arch of Clin Neuropsychol)
Week1
Cognitive Function
Time Frame: Week 8
Stroop colour and word test, (Williams et al., 1996, Psychol Bull) and Trail Making Test (Tombaugh, 2004, Arch of Clin Neuropsychol)
Week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 18, 2018

Primary Completion (Actual)

May 3, 2019

Study Completion (Actual)

May 3, 2019

Study Registration Dates

First Submitted

October 3, 2019

First Submitted That Met QC Criteria

October 3, 2019

First Posted (Actual)

October 7, 2019

Study Record Updates

Last Update Posted (Actual)

October 7, 2019

Last Update Submitted That Met QC Criteria

October 3, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017_03_18_EHS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

De-identified individual participant data for all primary and secondary outcomes measures will be made available.

IPD Sharing Time Frame

Primary outcome data will be made available for five years at six months following publication of primary outcome summary data. Secondary outcome data will be made available for five years at six months following publications of secondary outcome summary data.

IPD Sharing Access Criteria

Proposals should be directed to matthew.herring@ul.ie. To gain access, data requestors will need to sign a data access agreement.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analogue Generalized Anxiety Disorder

Clinical Trials on Resistance exercise training

3
Subscribe